Study of JNJ-74856665 in patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome
74856665AML1001
Phase 1 other active
Quick answer
Study of JNJ-74856665 in patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome for Acute myeloid leukemia or Myelodysplastic syndrome is a Phase 1 program (other) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Acute myeloid leukemia or Myelodysplastic syndrome
- Phase
- Phase 1
- Modality
- other
- Status
- active